hydroxypropyl-gamma-cyclodextrin has been researched along with naphthoquinones in 1 studies
| Studies (hydroxypropyl-gamma-cyclodextrin) | Trials (hydroxypropyl-gamma-cyclodextrin) | Recent Studies (post-2010) (hydroxypropyl-gamma-cyclodextrin) | Studies (naphthoquinones) | Trials (naphthoquinones) | Recent Studies (post-2010) (naphthoquinones) |
|---|---|---|---|---|---|
| 86 | 0 | 34 | 7,110 | 149 | 2,923 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beman, M; Boothman, DA; Bornmann, WG; Bruening, A; Gao, J; Nasongkla, N; Ray, D; Wiedmann, AF | 1 |
1 other study(ies) available for hydroxypropyl-gamma-cyclodextrin and naphthoquinones
| Article | Year |
|---|---|
Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adjuvants, Pharmaceutic; alpha-Cyclodextrins; Animals; beta-Cyclodextrins; Biological Availability; Cyclodextrins; gamma-Cyclodextrins; Humans; Injections, Intraperitoneal; Lethal Dose 50; Mice; Mice, Inbred C57BL; Naphthoquinones; Solubility; Tumor Cells, Cultured | 2003 |